Incidence and outcome of a 10-fold indomethacin overdose in premature infants

Journal of Pediatrics

Volumn 135, Issue 1, 1999, Pages 105-107

  Narayanan, Meera ^a   Schlueter, Mureen ^a   Clyman, Ronald I ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN;

ARTICLE; CASE REPORT; DRUG OVERDOSE; FEMALE; HUMAN; INCIDENCE; LOW BIRTH WEIGHT; MALE; NEWBORN; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

EID: 0033504326     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70337-9     Document Type: Article

References (17)

1. 1. Ment LR, Oh W, Ehrenkranz RA, Philip AG, Vohr B, Allan W, et al. Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomised trial. Pediatrics 1994;93:543-50.
2. 2. Cil'uentes RF, Olley PM, Balfe JW, Radde IC, Soldin SJ. Indomethacin and renal function in premature infants with persistent patent ductus arteriosus. J Pediatr 1979;95:583-7.
3. 3. Friedman Z, Whitman V, Maisels MJ, Berman W Jr, Marks KH, Vessel ES. Indomethacin disposition and indomethacin induced platelet dysfunction in premature infants. J Clin Pharmacol 1978;18:272-9.
4. 4. Meyers RL, Alpan G, Lin E, Clyman RI. Patent ductus arteriosus, indomethacin, and intestinal distension: effects on intestinal blood flow and oxygen consumption. Pediatr Res 1991;29:569-74.
5. 5. Gleason CA, Clyman RI, Heymann MA, Mauray F, Leake R, Roman C. Indomethacin and patent ductus arteriosus: effects on renal function in preterm lambs. Am J Physiol 1988; 254:F38-44.
6. 6. Leffler CW, Busija DW, Beasley DG, Fletcher AM. Maintenance of cerebral circulation during hemorrhagic hypotension in newborn pigs: role of proslanoids. Circ Res 1986;59:562-7.
7. 7. Chemtob S, Benarry K, Rex J, Varma DR, Aranda JV. Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets. Stroke 1990;21:777-84.
8. 8. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1984;310:563-72.
9. 9. Gleason CA. Prostaglandins and the developing kidney. Semin Perinatol 1987;11:12-21.
10. 10. Scholz TD, McGuinness CA. Localized intestinal perforation following intravenous indomethacin for patent ductus arteriosus. J Pediatr Gastroenterol Nutr 1988;7:773-5.
11. 11. Wolf WM, Snover DC, Leonard AS. Localized intestinal perforation following intravenous indomethacin in premature infants. J Pediatr Surg 1989; 24:409-10.
12. 12. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weight < 1500 grams. J Pediatr 1978; 92:529-34.
13. 13. Bell MJ. Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978;187;1-7.
14. 14. Gersony WM, Peckham GJ. Ellison RC, Miettinen OS, Nadas AS. Effects of indometharin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983;102:895-906.
15. 15. Mahony L, Caldwell RL, Girod DA, Hurwitz RA, Jansen RD, Lemons JA, et al. Indomethacin therapy on the first day of life in infants with very low birth weight. J Pediatr 1985;106: 801-5.
16. 16. Clyman RI. Commentary: recommendations for the postnatal use of indomethacin. An analysis of four separate treatment strategies. J Pediatr 1996;128:601-7.
17. 17. Snedecor GW, Cochran WG. Statistical methods. Ames (IA): Iowa State University Press; 1967. p. 221.